In less than a year, CDL Kasauli distributes about 1512 million doses of COVID-19 vaccination.

Indias Covid vaccination campaign has centered at the Central Drugs Laboratory in Kasauli, which is based in the Himalayan mountains. The safety element is maintained by examining each and every batch of vaccines before they are listed on the market by a government lab.

Shalini Bhardwaj Kasauli (Himachal Pradesh) India November 26: Since its inception early this year, India's Covid vaccination campaign has centered at the Central Drugs Laboratory in Kasauli, which is based in the Himalayan mountains.CDL Kasauli has already received 1,049 batches of all the indigenous manufacturers and from imported vaccines, which is equal to almost 150 crore doses, according to Dr Eswara Reddy, the Joint Drugs Controller General of India.During a meeting with health journalists at CDL Kasauli, Dr Reddy explained how it is the government's job to guarantee the safety, quality, and the effectiveness of the products before they are released into the market.Clinical studies have proven to be effective and safe.

Also, this vaccine must be tested before being introduced into the market.He said, We will guarantee the quality of the product by doing so.It is the dream of India's government, particularly Health Minister Mansukh Mandaviya, he said.The purpose of the meeting, he said, is to educate people about the different processes involved before getting vaccines into the market.You can see what test method we are using, what are the different variables we're testing, so there will be a tinkering with confidence in the product's functionality.

At present, there are three major indigenous COVID-19 vaccine manufacturers in India.We have three major indigenous manufacturers in India, Bharat Biotech manufacturing Covaxin, Serum Institute of India manufacturing Covishield, and the Zydus Cadilas DNA vaccine.These are the three majors, and in addition to this, we also have Hetero pharmaceutical laboratories, which also manufacture the SputnikV, according to him.

.
.
.
.